TG Therapeutics, Inc. (TGTX) stock analysis
TGTX · TG Therapeutics, Inc.
Latest recorded price: USD 62.76
Sector and industry: Healthcare · Biotechnology
A reliable intrinsic value could not be calculated for TGTX; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 504.9%, free cash flow margin -4.1%, ROIC 11.6%. The model flags 2 risk signals for this company (1 high severity).